SCHEMBL1809500

SCHEMBL1809500

COc1cc(OC)c2c(NCc3cc(S(N)(=O)=O)ccc3OC)ncnc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.53
▸ TNNI3K Q59H18 2/20 0.53
▸ LMNA P02545 5/20 0.49
▸ SRC P12931 1/20 0.47
▸ AURKA O14965 1/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ MAPK8 P45983 1/20 0.42
▸ EGFR P00533 3/20 0.41
▸ ERBB3 P21860 1/20 0.41
▸ CYP1A2 P05177 4/20 0.41
▸ CYP3A4 P08684 4/20 0.41
▸ CYP2C9 P11712 4/20 0.41
▸ CYP2C19 P33261 4/20 0.41
▸ CYP2D6 P10635 3/20 0.41
▸ CLK4 Q9HAZ1 3/20 0.41
▸ USP2 O75604 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807652 0.92 TNNI3K (0.52) BRAFTNNI3KLMNASRCAURKA
SCHEMBL1808559 0.91 TNNI3K (0.62) BRAFTNNI3KLMNASRCAURKA
SCHEMBL1806719 0.90 BRAF (0.46) BRAFTNNI3KLMNASRCMAPK1
Hydrochloric Acid SCHEMBL1804254 0.90 TNNI3K (0.61) BRAFTNNI3KLMNASRCAURKA
SCHEMBL1804276 0.89 BRAF (0.45) BRAFTNNI3KLMNASRCMAPK1
Hydrochloric Acid SCHEMBL1804960 0.88 BRAF (0.49) BRAFTNNI3KLMNASRCMAPK1
SCHEMBL1807965 0.86 TNNI3K (0.46) BRAFTNNI3KLMNASRCAURKA
SCHEMBL1807400 0.85 TNNI3K (0.55) BRAFTNNI3KLMNASRCAURKA
SCHEMBL1809126 0.84 SRC (0.43) BRAFTNNI3KLMNASRCEGFR
Trifluoroacetic Acid SCHEMBL1805887 0.83 BRAF (0.46) BRAFTNNI3KLMNASRCAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 — — EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 — — WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 — — EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 — — WO disclosed
Send feedback